Status:
COMPLETED
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Acute Myeloid Leukemia
Brief Summary
The treatment of very elderly patients (≥70 years) with acute myeloid leukemia remains controversial. Although the outcome in younger adults has improved because of cytarabine- and anthracycline-based...
Eligibility Criteria
Inclusion
- Have a diagnosis of AML according to World Health Organization (WHO) classification
- Are at least 70 years of age
Exclusion
- \- Patients with M3 AML of FAB classification (APL, Acute Promyelocytic Leukemia)
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT03350152
Start Date
January 1 2000
End Date
June 1 2014
Last Update
November 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CORTIAL
Pierre-Bénite, Rhone, France, 69310